StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · TRIB·Healthcare

Trinity Biotech plc Stock Analysis & AI Score

Trinity Biotech plc (TRIB) has an ST Score of 41.1 (C), driven by its Valuation (B) and held back by its Momentum (D-). Analysts rate it Buy.

Market Closed
$6.95
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
41
ST Score
41.1/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Specialties
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

TRIB
41.1out of 100
Grade C

Trinity Biotech plc (TRIB) has an ST Score of 41.1 (C), driven by its Valuation (B) and held back by its Momentum (D-). Analysts rate it Buy.

Strongest
ValuationB
Weakest
MomentumD-
All factor grades
  • ValuationB
  • ProfitabilityC+
  • GrowthC+
  • Financial StrengthC
  • MomentumD-
  • Piotroski3/9
Score methodology
Press Releases

Contact

TRIB stock: frequently asked questions

What is TRIB's ST Score?

Trinity Biotech plc (TRIB) has an ST Score of 41.1 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is TRIB a buy, hold, or sell?

Analysts rate TRIB a Buy. Our ST Score grades it C (41.1/100). The ST Score is a data-driven signal, not a recommendation.

What are TRIB's factor grades?

Valuation B, Profitability C+, Financial Strength C, Momentum D-, Growth C+.

What is TRIB's valuation grade?

Trinity Biotech plc (TRIB) earns a valuation grade of B, measured against Medical - Specialties peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is TRIB's growth grade?

Trinity Biotech plc (TRIB) earns a growth grade of C+, measured against Medical - Specialties peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is TRIB's profitability grade?

Trinity Biotech plc (TRIB) earns a profitability grade of C+, measured against Medical - Specialties peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is TRIB's financial strength grade?

Trinity Biotech plc (TRIB) earns a financial strength grade of C, measured against Medical - Specialties peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is TRIB's Piotroski score?

Trinity Biotech plc (TRIB) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.